// App-Quantinova.ai

1069 : OX40/CD137 dual agonism potentiates anti-tumour immunity by driving functional reprogramming and instability of regulatory T (Treg) cells

Researchers

Presenter

  • Charlotte Imianowski

Principal Investigators

  • Paula Kuo

  • Edmund Poon

  • Matthew Lakins

  • Michelle Morrow

  • Rahul Roychoudhuri

Medical Centers

  • F-star Therapeutics Ltd, Cambridge, UK

  • University of Cambridge, Cambridge, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Regulatory T cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved